Baird downgraded Argenx (ARGX) to Neutral from Outperform with a price target of $650, up from $515. The stock is up 65% to a $35B market capitalization over the last six months, driven by the strong last two quarters of revenue along with the R&D day event in July that unveiled the company’s “Vision 2030,” the analyst tells investors in a research note. The firm believes the stock is now pricing in “very strong growth” for Vyvgart over the coming quarters along with some substantial pipeline credit. Meanwhile, it sees the coming months as lighter on catalysts.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on ARGX:
- Argenx Reports Strong Q3 2024 Financial Results
- Argenx price target raised to $660 from $540 at Truist
- Argenx SE’s Strong Q3 Results and Future Outlook
- Argenx reports Q3 EPS $1.39, consensus 3c
- Is ARGX a Buy, Before Earnings?
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
